Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
10:38am, Thursday, 11'th Aug 2022
Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac. The post Pharma Stocks GSK, Sanofi And Haleon Lose Billions As
Drug stocks under pressure over Zantac litigation concerns
10:35am, Thursday, 11'th Aug 2022
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss alleged concerns that Sanofi and GSK's antacid drug Zantac causes cancer.
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
10:03am, Thursday, 11'th Aug 2022 Benzinga
Sonos, Inc. (NASDAQ: SONO) shares fell 20.4% to $18.11 in pre-market trading after the company reported weaker-than-expected sales results for its third quarter and issued downbeat FY22 sales guidance
GSK, Sanofi and Haleon slump on worries over Zantac litigation
07:18am, Thursday, 11'th Aug 2022
European-listed shares of drugmakers Haleon HLN, -11.81% , GSK GSK, -8.48% and Sanofi SAN, -8.81% plunged on Thursday on worries over the Zantac heartburn medication litigation. The first trial is set
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
03:53pm, Friday, 05'th Aug 2022 Zacks Investment Research
Theravance (TBPH) reports narrower-than-expected loss in the second quarter of 2022. Revenues improve year over year due to Viatris collaboration.
Gilead (GILD) Q2 Earnings & Sales Top, Revenue Outlook Upped
01:53pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Gilead (GILD) reports better-than-expected second quarter results on strong HIV business. The company also raises its annual revenue guidance.
Is Nuveen ESG International Developed Markets Equity ETF (NUDM) a Strong ETF Right Now?
10:20am, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Smart Beta ETF report for NUDM
The Zacks Analyst Blog Highlights GSK, Merck, Pfizer, Sanofi and AstraZeneca
12:10pm, Monday, 01'st Aug 2022 Zacks Investment Research
GSK, Merck, Pfizer, Sanofi and AstraZeneca are part of Zacks top Analyst Blog.
3 Fast-Growing Stocks to Buy Now
01:00pm, Sunday, 31'st Jul 2022 The Motley Fool
ShockWave, Vir, and BioCryst are all seeing skyrocketing sales this quarter.
2 Biotech Stocks That Could Help Make You a Fortune
10:15am, Saturday, 30'th Jul 2022 The Motley Fool
These companies have seen triple-digit revenue growth in recent years.
GSK or Haleon: Which Is the Real Beneficiary of This Spinoff?
05:47pm, Wednesday, 27'th Jul 2022
GSK PLC ( GSK , Financial) completed the long-awaited spinoff of its consumer health care business Haleon ( HLN , Financial) on July 18. Shareholders received one Haleon share for each GSK share owned
Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell
08:56am, Wednesday, 27'th Jul 2022
Early Wednesday, GSK stock dipped slightly despite beating second-quarter expectations and raising its full-year guidance. The post Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell ap
GSK Raises Full-Year Forecast
04:49am, Wednesday, 27'th Jul 2022
The pharmaceutical company says it expects adjusted operating profit for the year to rise 13% to 15%, higher than previous guidance of 12% to 14%.
GSK raises full-year guidance after bumper second quarter; shingles drug the star performer
02:46am, Wednesday, 27'th Jul 2022
GSK PLC (LSE:GSK, NYSE:GSK) has raised its full-year guidance after a bumper second quarter that exceeded City expectations. The drugs giant now expects 2022 sales to increase by 6% to 8%, compared wi
GSK lifts full-year forecast, days after consumer health spinoff
02:26am, Wednesday, 27'th Jul 2022
GSK on Wednesday lifted its full-year forecast, boosted by reinvigorated demand for its blockbuster Shingrix vaccine, days after overhauling the business with the spinoff of its consumer health unit.
